Discovery
Clinical Pharmacology & Therapeutics (2007) 82, 310–315; doi:10.1038/sj.clpt.6100278; published online 27 June 2007
Human Embryonic Stem Cell Derivation and Nuclear Transfer: Impact on Regenerative Therapeutics and Drug Discovery
1Cellular Reprogramming Laboratory, Centro de Investigación Príncipe Felipe, Valencia, Spain
Correspondence: M Stojkovic, (mstojkovic@cipf.es)
Abstract
This review aims to introduce current and future uses of human embryonic stem cells derived from in vitro-fertilized embryos. These and stem cells derived from parthenogenetic and nuclear transfer embryos could be used for cell therapy, as in vitro cell models for drug discovery/screening, and for studying early human development and pathogenesis of human diseases. However, development of therapeutic and screening applications and products from embryonic stem cells is hampered by several barriers. Therefore, gaps in our current understanding of the basic science of stem cells need to be filled before either application can move forward with confidence.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Stem cells The magic brewNature News and Views (19 Jul 2007)
Stem cells Recycling the abnormalNature News and Views (07 Jun 2007)
See all 3 matches for News And Views